Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain J Chen, HJ Lee, X Wu, L Huo, SJ Kim, L Xu, Y Wang, J He, LR Bollu, ... Cancer research 75 (3), 554-565, 2015 | 168 | 2015 |
Molecular pathways: targeting protein tyrosine phosphatases in cancer LR Bollu, A Mazumdar, MI Savage, PH Brown Clinical Cancer Research 23 (9), 2136-2142, 2017 | 145 | 2017 |
Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, JA Sosman, B Zhang, ... Frontiers in immunology 11, 1185, 2020 | 144 | 2020 |
Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression AM Blessing, K Rajapakshe, L Reddy Bollu, Y Shi, MA White, AH Pham, ... Autophagy 13 (3), 506-521, 2017 | 110 | 2017 |
ATP citrate lyase mediates resistance of colorectal cancer cells to SN38 Y Zhou, LR Bollu, F Tozzi, X Ye, R Bhattacharya, G Gao, E Dupre, L Xia, ... Molecular cancer therapeutics 12 (12), 2782-2791, 2013 | 92 | 2013 |
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells NR Candelaria, S Addanki, J Zheng, T Nguyen-Vu, H Karaboga, P Dey, ... PloS one 9 (9), e106289, 2014 | 63 | 2014 |
Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, B Nguyen, M Genet, ... Clinical cancer research 27 (23), 6514-6528, 2021 | 60 | 2021 |
Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation LR Bollu, RR Katreddy, AM Blessing, N Pham, B Zheng, X Wu, Z Weihua Oncotarget 6 (33), 34992, 2015 | 58 | 2015 |
Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells LR Bollu, J Ren, AM Blessing, RR Katreddy, G Gao, L Xu, J Wang, F Su, ... Cell cycle 13 (15), 2415-2430, 2014 | 57 | 2014 |
SOX9 is essential for triple-negative breast cancer cell survival and metastasis Y Ma, J Shepherd, D Zhao, LR Bollu, WM Tahaney, J Hill, Y Zhang, ... Molecular Cancer Research 18 (12), 1825-1838, 2020 | 51 | 2020 |
EGFR–SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors J Ren, LR Bollu, F Su, G Gao, L Xu, WC Huang, MC Hung, Z Weihua The Prostate 73 (13), 1453-1461, 2013 | 47 | 2013 |
Glioblastoma as an age-related neurological disorder in adults M Kim, E Ladomersky, A Mozny, M Kocherginsky, K O’Shea, ZZ Reinstein, ... Neuro-oncology advances 3 (1), vdab125, 2021 | 46 | 2021 |
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors S Otto-Meyer, R DeFaccio, C Dussold, E Ladomersky, L Zhai, KL Lauing, ... Brain, Behavior, & Immunity-Health 2, 100025, 2020 | 31 | 2020 |
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt RR Katreddy, LR Bollu, F Su, N Xian, S Srivastava, R Thomas, Y Dai, ... Oncogenesis 7 (1), 5, 2018 | 31 | 2018 |
Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor N-terminus AM Blessing, S Ganesan, K Rajapakshe, Y Ying Sung, L Reddy Bollu, ... Molecular endocrinology 29 (10), 1426-1439, 2015 | 30 | 2015 |
Sodium/glucose co-transporter 1 expression increases in human diseased prostate A Blessing, L Xu, G Gao, LR Bollu, J Ren, H Li, X Wu, F Su, WC Huang, ... J Cancer Sci Ther 4 (9), 306-312, 2012 | 23 | 2012 |
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1 LR Bollu, J Shepherd, D Zhao, Y Ma, W Tahaney, C Speers, A Mazumdar, ... NPJ Breast cancer 6 (1), 2, 2020 | 20 | 2020 |
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression A Mazumdar, WM Tahaney, L Reddy Bollu, G Poage, J Hill, Y Zhang, ... NPJ Breast Cancer 5 (1), 22, 2019 | 19 | 2019 |
Alcohol regulates genes that are associated with response to endocrine therapy and attenuates the actions of tamoxifen in breast cancer cells NR Candelaria, R Weldon, S Muthusamy, T Nguyen-Vu, S Addanki, ... PLoS One 10 (12), e0145061, 2015 | 18 | 2015 |
Identification and characterization of a novel indoleamine 2, 3-dioxygenase 1 protein degrader for glioblastoma LR Bollu, PV Bommi, PJ Monsen, L Zhai, KL Lauing, A Bell, M Kim, ... Journal of Medicinal Chemistry 65 (23), 15642-15662, 2022 | 11 | 2022 |